SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
ASTERIAS BIOTHERAPEUTICS, INC.
(Exact name of Registrant as specified in charter)
Delaware 2836 46-1047971
(State or other jurisdiction of
incorporation or organization) (Primary Standard Industrial
Classification Code Number) (I.R.S. Employer
PETER S. GARCIA, Chief Financial Officer
230 Constitution Drive Asterias Biotherapeutics, Inc.
Menlo Park, California 94025 1301 Harbor Bay Parkway, Suite 100
(650) 433-2900 Alameda, California 94504
(Address, including zip code, (510) 521-3390
and telephone number, including area code, (Name, address, including zip code, and telephone number,
of Registrant’s principal executive offices) including area code, of agent for service)
Copies of all communications, including all communications sent to the agent for service, should be sent to:
THOMAS OKARMA RICHARD S. SOROKO, ESQ.
Chief Executive Officer Thompson, Welch, Soroko & Gilbert LLP
Asterias Biotherapeutics, Inc. 235 Pine Street, 13th Floor
230 Constitution Drive San Francisco, California 94104
Menlo Park, California 94025 Tel. (415) 448-5000
Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 of the Securities Act of 1933 check the following box. x
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement numb